Watchlist Price Alert

Kyverna Therapeutics Inc. (KYTX)

NASDAQ: KYTX · Real-Time Price · USD

2.27

0.05 (2.25%)

At close: May 02, 2025, 3:59 PM

2.28

0.44%

After-hours: May 02, 2025, 04:05 PM EDT

Kyverna Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	282K
Cost of Revenue	n/a	n/a	530K	482K	462K	438K	413K	8.71M	374K
Gross Profit	n/a	n/a	-530K	-482K	-462K	-438K	-413K	-8.71M	-92K
Operating Income	-41.04M	-38.77M	-33.44M	-29.36M	-21.38M	-16.28M	-13.3M	-11.45M	-8.78M
Interest Income	3.58M	4.36M	4.69M	2.73M	789K	880K	264K	349K	297K
Pretax Income	-37.49M	-34.49M	-28.8M	-26.69M	-20.67M	-15.46M	-13.09M	-11.14M	-8.5M
Net Income	-37.49M	-34.49M	-28.8M	-26.69M	-20.67M	-15.46M	-13.09M	-11.14M	-8.5M
Selling & General & Admin	7.56M	9.58M	6.11M	6.88M	4.21M	2.64M	2.9M	2.73M	1.99M
Research & Development	32.92M	29.19M	27.32M	22.48M	17.16M	13.21M	9.99M	8.71M	7.07M
Other Expenses	n/a	n/a	n/a	-26K	-32K	-13K	-7K	-3K	23K
Operating Expenses	41.04M	38.77M	33.44M	29.36M	21.38M	15.84M	12.89M	11.45M	9.06M
Interest Expense	27K	32K	39K	44K	47K	50K	46K	44K	41K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	41.04M	38.77M	33.44M	29.36M	21.38M	16.28M	13.3M	11.45M	9.06M
Income Tax Expense	n/a	n/a	n/a	18K	15K	n/a	n/a	41K	64K
Shares Outstanding (Basic)	43.21M	43.16M	43.13M	23.75M	43.12M	43.12M	43.12M	25.8M	43.12M
Shares Outstanding (Diluted)	43.21M	43.16M	43.13M	23.75M	43.12M	43.12M	43.12M	25.8M	43.12M
EPS (Basic)	-0.92	-0.8	-0.67	-1.12	-0.48	-0.36	-0.3	-0.43	-0.2
EPS (Diluted)	-0.92	-0.8	-0.67	-1.12	-0.48	-0.36	-0.3	-0.43	-0.2
EBITDA	-36.9M	-33.9M	-28.23M	-26.17M	-20.16M	-14.98M	-12.63M	-10.71M	-8.08M
EBIT	-37.46M	-34.46M	-28.76M	-26.65M	-20.62M	-15.41M	-13.04M	-11.1M	-8.46M
Depreciation & Amortization	563K	558K	530K	482K	462K	438K	413K	394K	374K